Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics. AMCR [Internet]. 2025 Dec. 15 [cited 2026 Aug. 14];7(1):1-18. Available from: https://hmpublisher.com/index.php/AMCR/article/view/831